Rockefeller Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,577
Closed -$992K 3717
2021
Q1
$992K Sell
4,577
-17,141
-79% -$3.22M 0.01% 785
2020
Q4
$2.51M Buy
21,718
+6,019
+38% +$674K 0.02% 465
2020
Q3
$1.53M Buy
15,699
+14,023
+837% +$1.61M 0.01% 495
2020
Q2
$206K Buy
1,676
+1,109
+196% +$126K ﹤0.01% 942
2020
Q1
$50K Sell
567
-2,297
-80% -$243K ﹤0.01% 1239
2019
Q4
$299K Sell
2,864
-29
-1% -$3.25K ﹤0.01% 680
2019
Q3
$333K Buy
2,893
+6
+0.2% +$911 ﹤0.01% 537
2019
Q2
$498K Sell
2,887
-6,040
-68% -$1.04M 0.01% 450
2019
Q1
$1.5M Buy
+8,927
New +$1.33M 0.02% 304

Other funds holding GWPH

Rockefeller Capital Management's GWPH Position: Q2 2021 in Review

Rockefeller Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,577 shares — an estimated $992K sold.

Rockefeller Capital Management first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $2.51M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Rockefeller Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 4,577 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $992K.
  • Rockefeller Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
  • Rockefeller Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.51M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Rockefeller Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.